FSMAX
Price
$77.78
Change
+$0.62 (+0.80%)
Updated
Apr 17 closing price
Net Assets
36.55B
NMGAX
Price
$14.97
Change
+$0.09 (+0.60%)
Updated
Apr 17 closing price
Net Assets
1.62B
Ad is loading...

FSMAX vs NMGAX

Header iconFSMAX vs NMGAX Comparison
Open Charts FSMAX vs NMGAXBanner chart's image
Fidelity Extended Market Index
Price$77.78
Change+$0.62 (+0.80%)
VolumeN/A
Net Assets36.55B
Neuberger Berman Mid Cap Growth A
Price$14.97
Change+$0.09 (+0.60%)
VolumeN/A
Net Assets1.62B
FSMAX vs NMGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMAX vs. NMGAX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and NMGAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 36.5B vs. NMGAX (1.62B). FSMAX pays higher dividends than NMGAX: FSMAX (0.53) vs NMGAX (0.00). FSMAX was incepted earlier than NMGAX: FSMAX (14 years) vs NMGAX (16 years). NMGAX (1.06) is less costly to investors than FSMAX (0.04). NMGAX is a more actively managed with annual turnover of: 97.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than NMGAX: FSMAX (0) vs NMGAX (1000). FSMAX annual gain was more profitable for investors over the last year : 0.35 vs. NMGAX (-7.58). FSMAX return over 5 years is better than : 60.85 vs. NMGAX (2.48).
FSMAXNMGAXFSMAX / NMGAX
Total Expense Ratio0.041.063%
Annual Report Gross Expense Ratio0.041.063%
Fund Existence14 years16 years-
Gain YTD-15.097-11.848127%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets36.5B1.62B2,257%
Annual Yield % from dividends0.530.00-
Returns for 1 year0.35-7.58-5%
Returns for 3 years5.53-6.88-80%
Returns for 5 years60.852.482,457%
Returns for 10 years44.713.281,362%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDYA17.080.90
+5.56%
IDEAYA Biosciences
PRLD0.810.04
+5.19%
Prelude Therapeutics
FCFS121.441.38
+1.15%
FirstCash Holdings
EGHT1.58N/A
N/A
8x8
INFY16.14-0.44
-2.65%
Infosys Limited